The Open Markets Institute filed an amicus brief in Ryan v. FTC, marking the second appellate case in which Open Markets has defended the Federal Trade Commission’s (FTC) landmark prohibition on non-compete clauses.

On Monday, December 9, the Federal Trade Commission (FTC) modified a 12-year-old consent order that previously prohibited independent pharmacies in Puerto Rico from collectively bargaining with pharmacy benefit managers (PBMs) and insurers.

In this issue, we take a look at how the fight to rein in Big Tech giants is moving to the states as the future for antitrust enforcement remains uncertain under the incoming Trump administration and Republican-controlled Congress.

Legal director Sandeep Vaheesan and chief economist Brian Callaci advocate for rent control in Atlanta as a vital solution to combat housing affordability issues and economic inequality.

The Open Markets Institute filed an amicus brief with the U.S. Court of Appeals for the Third Circuit, urging the court to grant a rehearing In re Merck Mumps Vaccine Antitrust Litigation. A class of physicians alleged that Merck misled the Food and Drug Administration about the shelf-life of its vaccine and thereby kept out a competing vaccine.

In this issue, we look at one of the first challenges the Trump Administration will face — as ocean freight carriers exploit their monopoly to drive freight rates to unprecedented levels. We also look at the DOJ’s plan to break up Google. In this issue,

The Open Markets Institute filed an amicus brief in Villages v. FTC, one of two cases that challenge the FTC’s landmark prohibition on non-compete clauses.

In this issue,  we look at the lessons of the U.S. presidential election, and some next steps. We also explore how the EU’s AI strategy might concentrate even more power in the hands of Big Tech.

Legal director Sandeep Vaheesan writes on the potential rescue to come to small businesses if Kamala Harris wins the upcoming election, shifting the cooperation of the FTC towards independent corporations.